StonvexLoading…
StonvexStonvexStonvexCore line items from POET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.07M | $41.43K | $465.78K | $552.75K |
Operating Income | $-62.96M | $-56.70M | $-20.27M | $-21.04M |
Net Income | $-62.96M | $-56.70M | $-20.27M | $-21.04M |
EPS (Diluted) | $-0.68 | $-0.94 | $-0.51 | $-0.57 |
Total Assets | $328.57M | $69.65M | $8.78M | $15.39M |
Total Liabilities | $144.78M | $48.96M | $3.85M | $3.95M |
Cash & Equivalents | $39.96M | $37.14M | $3.02M | $9.23M |
Free Cash Flow OCF − CapEx | $-33.34M | $-30.07M | $-16.58M | $-15.34M |
Shares Outstanding | 132.02M | 76.51M | 42.49M | 37.84M |